ABT · News · 20261030N

Diagnostic Market Demand

ABBOTT LABORATORIES · 2026-10-30 · Importance 30 · Surprise 40

The report projects the global point-of-care INR testing market to grow from $1.58 billion in 2025 to $1.75 billion in 2026, a 10.4% CAGR. It attributes growth to cardiovascular disease prevalence, anticoagulant use, and demand for faster coagulation testing. Abbott is named alongside Roche, Danaher, and Siemens Healthineers as a company scaling in the market; the report highlights home monitoring, recurring consumables, distribution partnerships, and local assembly as market opportunities.